OncoMyx utilizes the Myxoma virus as both an oncolytic virus and a vehicle to deliver immunomodulatory proteins to treat a variety of both solid and liquid tumors to achieve the greatest therapeutic benefit for cancer patients.

OncoMyx utilizes the Myxoma virus as both an oncolytic virus and a vehicle to deliver immunomodulatory proteins to treat a variety of both solid and liquid tumors to achieve the greatest therapeutic benefit for cancer patients.